H Hasan New member 27 Haz 2022 #1 For treatment of some breast cancers, 2 drugs approved by European Union Enhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi Sankyo.
For treatment of some breast cancers, 2 drugs approved by European Union Enhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi Sankyo.
